Article Information
History
- December 21, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yongin Cho1,
- Sung-Hee Shin2,##,*,
- Min-Ae Park3,
- Young Ju Suh4,
- Sojeong Park3,
- Ji-Hun Jang2,
- Dae-Young Kim2 and
- So Hun Kim1,#,*
- 1Department of Endocrinology and Metabolism, Inha University College of Medicine, Incheon, Republic of Korea
- 2Department of Cardiology, Inha University College of Medicine, Incheon, Republic of Korea
- 3Department of Data Science, Hanmi Pharm Co., Ltd
- 4Department of Biomedical Sciences, Inha University College of Medicine, Incheon, Korea
- ↵#Corresponding author 1:
So Hun Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Inha University College of Medicine 27, Inhang-ro, Joong-gu, Incheon 22332, Korea Phone: +82-32-890-3573 E-mail: shoney{at}inha.ac.kr - ##Corresponding author 2:
Sung-Hee Shin Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine 27, Inhang-ro, Joong-gu, Incheon 22332, Korea Phone: +82-32-890-2114 E-mail: sshin{at}inha.ac.kr
↵* These authors have contributed equally to this work and share corresponding authorship.
Posted December 21, 2023.
The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation
